FindTrial
Sign In

the influence of phrenic nerve conduction diaphragmatic excursion pulmonary function following Supraclavicular brachial plexus block by ultrasound-guided

the influence of phrenic nerve conduction diaphragmatic excursion pulmonary function following Supraclavicular brachial plexus block by ultrasound-guided

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IND-17012166
Enrollment
Unknown
Registered
2017-07-27
Start date
2017-07-26
Completion date
Unknown
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diaphragmatic paralysis

Interventions

Two groups:0.375% ropivacaine 20ml versus 30ml supraclavicular brachial plexus block

Sponsors

the 98th PLA Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ulnoradial fracture internal fixaton removal patients, aged 18~65 years old, 45~80kg weight, 155~180cm height, ASAI~II, no obvious abnomal cardipulmonary function

Exclusion criteria

Exclusion criteria: BMI>30, arrhythmia, respiratory system disease, injection site infection, severe hepatic dysfunction, blood hemostasis system disease, per limb sensorimotor function, allergic reaction to local anesthetic recent sustained use of painkillers.

Design outcomes

Primary

MeasureTime frame
phrenic nerve conduction time;diaphragmatic compound muscle action potential;pulmonary function;diaphragmatic excursion;—

Secondary

MeasureTime frame
sensory block;motor block;dyspnea;—

Countries

China

Contacts

Public ContactWang Xianghe

the 98th PLA Hospital

863097@sina.com+86 13396726086

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 22, 2026